Candel Therapeutics Inc (CADL)
12.70
+2.00
(+18.69%)
USD |
NASDAQ |
May 15, 15:16
Candel Therapeutics Cash from Investing (Quarterly): -0.027M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.027M |
| September 30, 2023 | -0.103M |
| June 30, 2023 | -0.169M |
| March 31, 2023 | 0.019M |
| December 31, 2022 | -0.276M |
| September 30, 2022 | -0.215M |
| June 30, 2022 | -0.635M |
| March 31, 2022 | -0.171M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.504M |
| September 30, 2021 | -0.392M |
| June 30, 2021 | -0.71M |
| March 31, 2021 | -0.229M |
| December 31, 2020 | 20.18M |
| September 30, 2020 | -0.732M |
| June 30, 2020 | -0.277M |
| March 31, 2020 | 19.28M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.732M
Minimum
Sep 2020
20.18M
Maximum
Dec 2020
2.190M
Average
-0.222M
Median
Cash from Investing (Quarterly) Benchmarks
| Allurion Technologies Inc | -0.398M |
| AngioDynamics Inc | 29.40M |
| Eliem Therapeutics Inc | 36.75M |
| Macrogenics Inc | 24.79M |
| GlycoMimetics Inc | -0.0074M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.422M |
| Cash from Financing (Quarterly) | -0.121M |
| Free Cash Flow | -34.70M |
| Free Cash Flow Per Share (Quarterly) | -0.2577 |
| Free Cash Flow Yield | -9.44% |